These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34098348)
21. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity. Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594 [TBL] [Abstract][Full Text] [Related]
22. Gd-complexes of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-1,4,7,10-tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents. Gu S; Kim HK; Lee GH; Kang BS; Chang Y; Kim TJ J Med Chem; 2011 Jan; 54(1):143-52. PubMed ID: 21141934 [TBL] [Abstract][Full Text] [Related]
23. Separation of Gd-humic complexes and Gd-based magnetic resonance imaging contrast agent in river water with QAE-Sephadex A-25 for the fractionation analysis. Matsumiya H; Inoue H; Hiraide M Talanta; 2014 Oct; 128():500-4. PubMed ID: 25059192 [TBL] [Abstract][Full Text] [Related]
24. Preparation of polymer-based magnetic resonance imaging contrast agent to visualize therapeutic angiogenesis. Jo J; Lin X; Nakahara T; Aoki I; Saga T; Tabata Y Tissue Eng Part A; 2013 Jan; 19(1-2):30-9. PubMed ID: 22838390 [TBL] [Abstract][Full Text] [Related]
25. Dual-functional probes towards in vivo studies of brain connectivity and plasticity. Mamedov I; Engelmann J; Eschenko O; Beyerlein M; Logothetis NK Chem Commun (Camb); 2012 Mar; 48(22):2755-7. PubMed ID: 22134380 [TBL] [Abstract][Full Text] [Related]
26. Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity. Carniato F; Tei L; Arrais A; Marchese L; Botta M Chemistry; 2013 Jan; 19(4):1421-8. PubMed ID: 23233428 [TBL] [Abstract][Full Text] [Related]
27. Dextran gadolinium complexes as contrast agents for magnetic resonance imaging to sentinel lymph nodes. Yan GP; Xu W; Yang L; Li L; Liu F; Guo QZ Pharm Res; 2010 Sep; 27(9):1884-92. PubMed ID: 20559699 [TBL] [Abstract][Full Text] [Related]
28. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review. Telgmann L; Sperling M; Karst U Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209 [TBL] [Abstract][Full Text] [Related]
29. Simple method for quantification of gadolinium magnetic resonance imaging contrast agents using ESR spectroscopy. Takeshita K; Kinoshita S; Okazaki S Chem Pharm Bull (Tokyo); 2012; 60(1):31-6. PubMed ID: 22223372 [TBL] [Abstract][Full Text] [Related]
30. Application of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agent. Nagaraja TN; Croxen RL; Panda S; Knight RA; Keenan KA; Brown SL; Fenstermacher JD; Ewing JR J Neurosci Methods; 2006 Oct; 157(2):238-45. PubMed ID: 16769125 [TBL] [Abstract][Full Text] [Related]
31. Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry/separations/mass spectrometry. Telgmann L; Faber H; Jahn S; Melles D; Simon H; Sperling M; Karst U J Chromatogr A; 2012 Jun; 1240():147-55. PubMed ID: 22525874 [TBL] [Abstract][Full Text] [Related]
32. Gadolinium DTPA Enhancement Characteristics of the Rat Sciatic Nerve after Crush Injury at 4.7T. Hill BJ; Padgett KR; Kalra V; Marcillo A; Bowen B; Pattany P; Dietrich D; Quencer R AJNR Am J Neuroradiol; 2018 Jan; 39(1):177-183. PubMed ID: 29097415 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents. Li W; Li Z; Jing F; Deng Y; Wei L; Liao P; Yang X; Li X; Pei F; Wang X; Lei H Carbohydr Res; 2008 Mar; 343(4):685-94. PubMed ID: 18258223 [TBL] [Abstract][Full Text] [Related]